Wednesday, 26 August 2026European Markets

MEMSCAP REGPT Stock Went Up By Over 22% In The Last 10 Sessions

Loading stream...

(vianews) - shares of memscap regpt (cac 40: mems.pa) rose by a staggering 22.09% in 10 sessions from €1.72 to €2.10 at 19:07 est on tuesday, following the last session's upward trend. cac 40 is dropping 0.46% to €7,339.27, after three successive sessions in a row of gains.

memscap regpt's last close was €2.10, 1.45% higher than its 52-week high of €2.07.

about memscap regpt

memscap, s.a. provides micro-electro-mechanical systems (mems) based solutions for aerospace and defense, optical communications, medical and biomedical, and it/consumer markets worldwide. the company offers pressure sensors, pressure transducers, and pressure switches for various applications, such as air data computers, cabin pressure, engine control, altimeters, barometers, cockpit instruments, and air data test sets. it also provides gold coated and titanium-based pressure transducers, plastic domes, line-sets, and related accessories; and magnetic switches/relays, as well as supplies implantable pressure sensors for spinal pressure monitoring, abdominal aortic aneurism, etc. in addition, the company supplies optical mems chips for variable optical attenuators in optical telecommunication markets; and provides the multi-user mems processes (mumps) comprising polymumps, soimumps, and piezomumps, as well as mumps-plus and post processing services. further, it offers custom products, including wafers, mems dies, and wafer level packaged devices; and manufacturing services, as well as prototyping services. the company sells its products and services to fortune 500 companies, high-technology industries, research institutes, and universities. memscap, s.a. was founded in 1997 and is headquartered in crolles, france.

moving average

memscap regpt's worth is way above its 50-day moving average of €1.60 and way higher than its 200-day moving average of €1.24.

more news about memscap regpt (mems.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com
MEMSCAP REGPT Stock Went Up By Over 22% In The Last 10 Sessions | ViaNews EU